Increased mortality from cardiovascular diseases in Ukraine requires the development of new methods of treatment and prevention.
Identification of triglycerides level as a marker of ishemic heart disease caused the relevance of treatment options based on the correction of hypertriglyceridemia.
To effective means of correcting the levels of triglycerides and HDL include fibroic acid derivatives. But fibrates also raise a number of adverse side effects.
According to the results of the study obtained an objective assessment of the effectiveness of correction triglyceridemia patients (two groups of 20 patients) with fibrate therapy compared with combined fibrates-statins therapy.